Background MicroRNAs (miRNAs) have a crucial role in regulating immune response
against infectious diseases, showing changes early in disease onset and before the …

Background SARS-CoV-2 induces a spectrum of clinical conditions ranging from
asymptomatic infection to life threatening severe disease. Host microRNAs have been …

We aimed to examine the circulating microRNA (miRNA) profile of hospitalized COVID-19
patients and evaluate its potential as a source of biomarkers for the management of the …

The stratification of mortality risk in COVID-19 patients remains extremely challenging for
physicians, especially in older patients. Innovative minimally invasive molecular biomarkers …

The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis
and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 …

The role for circulating miRNAs as biomarkers of the COVID-19 disease remains uncertain.
We analysed the circulating miRNA profile in twelve COVID-19 patients with moderate …

Nowadays, the coronavirus disease (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a major global health …

Host microRNAs can influence the cytokine storm associated SARS-CoV-2 infection and
proposed as biomarkers for COVID-19 disease. In the present study, serum MiRNA-106a …

One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some
cases resulting in cytokine storm syndrome and acute respiratory distress syndrome …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19,
a pandemic associated with substantial morbidity and mortality. Despite of this, no vaccine …